These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31888257)

  • 1. Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients.
    Abdulrahman A; Eckstein M; Jung R; Guzman J; Weigelt K; Serrero G; Yue B; Geppert C; Stöhr R; Hartmann A; Wullich B; Wach S; Taubert H; Lieb V
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31888257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients.
    Eckstein M; Lieb V; Jung R; Sikic D; Weigelt K; Stöhr R; Geppert C; Weyerer V; Bertz S; Serrero G; Yue B; Hartmann A; Wullich B; Taubert H; Wach S
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients.
    König P; Eckstein M; Jung R; Abdulrahman A; Guzman J; Weigelt K; Serrero G; Hayashi J; Geppert C; Stöhr R; Hartmann A; Wullich B; Wach S; Taubert H; Lieb V
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32947898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival.
    Greither T; Fischer K; Theil G; Marcou M; Holzhausen HJ; Weigelt K; Serrero G; Hicks D; Yue B; Fornara P; Wullich B; Taubert H; Wach S; Lieb V
    Cancer Manag Res; 2018; 10():4173-4180. PubMed ID: 30323673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
    Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
    Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients.
    Fichte A; Neumann A; Weigelt K; Guzman J; Jansen T; Keinert J; Serrero G; Yue B; Stöhr R; Greither T; Hartmann A; Wullich B; Taubert H; Wach S; Lieb V
    Life (Basel); 2022 May; 12(5):. PubMed ID: 35629399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GP88/PGRN Serum Levels Are Associated with Prognosis for Oral Squamous Cell Carcinoma Patients.
    Greither T; Steiner T; Bache M; Serrero G; Otto S; Taubert H; Eckert AW; Kappler M
    Biology (Basel); 2021 May; 10(5):. PubMed ID: 34064411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Detection of Progranulin (PGRN/GP88/GEP) in Tumor Tissues as a Cancer Prognostic Biomarker.
    Serrero G; Hicks D
    Methods Mol Biol; 2018; 1806():107-120. PubMed ID: 29956272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
    Cattrini C; Rubagotti A; Nuzzo PV; Zinoli L; Salvi S; Boccardo S; Perachino M; Cerbone L; Vallome G; Latocca MM; Zanardi E; Boccardo F
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1257-e1265. PubMed ID: 30170989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomas.
    Yamamoto Y; Goto N; Takemura M; Yamasuge W; Yabe K; Takami T; Miyazaki T; Takeuchi T; Shiraki M; Shimizu M; Adachi S; Saito K; Shibata Y; Nakamura N; Hara T; Serrero G; Saito K; Tsurumi H
    Clin Chim Acta; 2017 Oct; 473():139-146. PubMed ID: 28823651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
    Tkaczuk KHR; Hawkins D; Yue B; Hicks D; Tait N; Serrero G
    Clin Breast Cancer; 2020 Jun; 20(3):220-227. PubMed ID: 31928925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects.
    Tkaczuk KR; Yue B; Zhan M; Tait N; Yarlagadda L; Dai H; Serrero G
    Breast Cancer (Auckl); 2011; 5():155-62. PubMed ID: 21792312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer.
    Zhang YF; Guan YB; Yang B; Wu HY; Dai YT; Zhang SJ; Wang JP; Anoopkumar-Dukie S; Davey AK; Sun ZY
    Chin Med J (Engl); 2011 Dec; 124(24):4345-9. PubMed ID: 22340411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients.
    Eckstein M; Jung R; Weigelt K; Sikic D; Stöhr R; Geppert C; Agaimy A; Lieb V; Hartmann A; Wullich B; Wach S; Taubert H
    Sci Rep; 2018 Dec; 8(1):17693. PubMed ID: 30523270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
    Quinn DI; Henshall SM; Head DR; Golovsky D; Wilson JD; Brenner PC; Turner JJ; Delprado W; Finlayson JF; Stricker PD; Grygiel JJ; Sutherland RL
    Cancer Res; 2000 Mar; 60(6):1585-94. PubMed ID: 10749127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells.
    Kim WE; Yue B; Serrero G
    Breast Cancer (Auckl); 2015; 9(Suppl 2):71-7. PubMed ID: 27168723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
    Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
    Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
    Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
    Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells.
    Tangkeangsirisin W; Serrero G
    Carcinogenesis; 2004 Sep; 25(9):1587-92. PubMed ID: 15117809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.